H19 induces abdominal aortic aneurysm development and progression

Circulation

Volumn 138, Issue 15, 2018, Pages 1551-1568

  Li, Daniel Y ^a   Busch, Albert ^a   Jin, Hong ^c   Chernogubova, Ekaterina ^c   Pelisek, Jaroslav ^a   Karlsson, Joakim ^d   Sennblad, Bengt ^e   Liu, Shengliang ^a   Lao, Shen ⁱ   Hofmann, Patrick ^f   Bäcklund, Alexandra ^c   Eken, Suzanne M ^c   Roy, Joy ^c   Eriksson, Per ^c   Dacken, Brian ^g   Ramanujam, Deepak ^b   Dueck, Anne ^b   Engelhardt, Stefan ^b   Boon, Reinier A ^f   Eckstein, Hans Henning ^a   Spin, Joshua M ^h   Tsao, Philip S ^h   Maegdefessel, Lars ^a,c   more..

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSITY OF GOTHENBURG   (Sweden)

^e UPPSALA UNIVERSITY   (Sweden)

^f UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^g Transova Genetics   (United States)

^h STANFORD UNIVERSITY   (United States)

ⁱ Stanford University ^*

Author keywords

Abdominal aortic aneurysm; Long noncoding RNA; Molecular medicine; Smooth muscle cells; Translations

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; BLOOD CLOTTING FACTOR 11; CHORIONIC GONADOTROPIN; ELASTASE; FIBRINOGEN; HYPOXIA INDUCIBLE FACTOR 1ALPHA; LONG UNTRANSLATED RNA; LOW DENSITY LIPOPROTEIN RECEPTOR; MICRORNA; MICRORNA 675; PANCREATIC ELASTASE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53; RNA H19; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR; TRANSCRIPTOME; TRIACYLGLYCEROL; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; H19 LONG NON-CODING RNA; HIF1A PROTEIN, HUMAN; HIF1A PROTEIN, MOUSE; TP53 PROTEIN, HUMAN; TRP53 PROTEIN, MOUSE;

ABDOMINAL AORTIC ANEURYSM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICOAGULANT THERAPY; APOPTOSIS; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LIGATION; LIVE CELL IMAGING; LUCIFERASE ASSAY; MALE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROXIMITY LIGATION ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA SEQUENCE; SEQUENCE ANALYSIS; SMOOTH MUSCLE CELL FUNCTION; WESTERN BLOTTING; ABDOMINAL AORTA; ANIMAL; APOLIPOPROTEIN E KNOCKOUT MOUSE; C57BL MOUSE; CASE CONTROL STUDY; CELL CULTURE; DISEASE EXACERBATION; DISEASE MODEL; GENETICS; LESIONS AND DEFECTS; METABOLISM; MINIPIG; PATHOLOGY; PIG; SMOOTH MUSCLE CELL; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANGIOTENSIN II; ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; APOPTOSIS; CASE-CONTROL STUDIES; CELLS, CULTURED; DILATATION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; MALE; MICE, INBRED C57BL; MICE, KNOCKOUT, APOE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; PANCREATIC ELASTASE; RECEPTORS, LDL; RNA, LONG NONCODING; SWINE; SWINE, MINIATURE; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 85055184587     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.117.032184     Document Type: Article

References (68)

1. Kent KC. Clinical practice. Abdominal aortic aneurysms. N Engl J Med. 2014;371:2101-2108. doi: 10.1056/NEJMcp1401430.
2. Li X, Zhao G, Zhang J, Duan Z, Xin S. Prevalence and trends of the abdominal aortic aneurysms epidemic in general population-a meta-analysis. PLoS One. 2013;8:e81260. doi: 10.1371/journal.pone.0081260.
3. Golledge J, Norman PE. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis. 2011;217:57-63. doi: 10.1016/j.atherosclerosis.2011.03.006.
4. Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, Ford E, Furie K, Go A, Greenlund K, Haase N, Hailpern S, Ho M, Howard V, Kissela B, Kittner S, Lackland D, Lisabeth L, Marelli A, McDermott M, Meigs J, Mozaffarian D, Nichol G, O'Donnell C, Roger V, Rosamond W, Sacco R, Sorlie P, Stafford R, Steinberger J, Thom T, Wasserthiel-Smoller S, Wong N, Wylie-Rosett J, Hong Y; American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119:480-486. doi: 10.1161/CIRCULATIONAHA.108.191259.
5. Golledge J, Muller J, Daugherty A, Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler Thromb Vasc Biol. 2006;26:2605-2613. doi: 10.1161/01.ATV.0000245819.32762.cb.
6. Vidigal JA, Ventura A. The biological functions of miRNAs: lessons from in vivo studies. Trends Cell Biol. 2015;25:137-147. doi: 10.1016/j.tcb.2014.11.004.
7. Engreitz JM, Ollikainen N, Guttman M. Long non-coding RNAs: spatial amplifiers that control nuclear structure and gene expression. Nat Rev Mol Cell Biol. 2016;17:756-770. doi: 10.1038/nrm.2016.126.
8. Maegdefessel L, Azuma J, Toh R, Deng A, Merk DR, Raiesdana A, Leeper NJ, Raaz U, Schoelmerich AM, McConnell MV, Dalman RL, Spin JM, Tsao PS. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci Transl Med. 2012;4:122ra22. doi: 10.1126/scitranslmed.3003441.
9. Maegdefessel L, Azuma J, Toh R, Merk DR, Deng A, Chin JT, Raaz U, Schoelmerich AM, Raiesdana A, Leeper NJ, McConnell MV, Dalman RL, Spin JM, Tsao PS. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest. 2012;122:497-506. doi: 10.1172/JCI61598.
10. Maegdefessel L, Spin JM, Raaz U, Eken SM, Toh R, Azuma J, Adam M, Nakagami F, Nagakami F, Heymann HM, Chernogubova E, Chernugobova E, Jin H, Roy J, Hultgren R, Caidahl K, Schrepfer S, Hamsten A, Eriksson P, McConnell MV, Dalman RL, Tsao PS. miR-24 limits aortic vascular inflammation and murine abdominal aneurysm development. Nat Commun. 2014;5:5214. doi: 10.1038/ncomms6214.
11. Li Y, Maegdefessel L. Non-coding RNA contribution to thoracic and abdominal aortic aneurysm disease development and progression. Front Physiol. 2017;8:429. doi: 10.3389/fphys.2017.00429.
12. Davis BT, Wang XJ, Rohret JA, Struzynski JT, Merricks EP, Bellinger DA, Rohret FA, Nichols TC, Rogers CS. Targeted disruption of LDLR causes hypercholesterolemia and atherosclerosis in Yucatan miniature pigs. PLoS One. 2014;9:e93457. doi: 10.1371/journal.pone.0093457.
13. Kloster BO, Lund L, Lindholt JS. Induction of continuous expanding infrarenal aortic aneurysms in a large porcine animal model. Ann Med Surg (Lond). 2015;4:30-35. doi: 10.1016/j.amsu.2014.10.001.
14. Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15-21. doi: 10.1093/bioinformatics/bts635.
15. Azuma J, Maegdefessel L, Kitagawa T, Dalman RL, McConnell MV, Tsao PS. Assessment of elastase-induced murine abdominal aortic aneurysms: comparison of ultrasound imaging with in situ video microscopy. J Biomed Biotechnol. 2011;2011:252141. doi: 10.1155/2011/252141.
16. Gomez D, Shankman LS, Nguyen AT, Owens GK. Detection of histone modifications at specific gene loci in single cells in histological sections. Nat Methods. 2013;10:171-177. doi: 10.1038/nmeth.2332.
17. Li Y, Sun XX, Elferich J, Shinde U, David LL, Dai MS. Monoubiquitination is critical for ovarian tumor domain-containing ubiquitin aldehyde binding protein 1 (Otub1) to suppress UbcH5 enzyme and stabilize p53 protein. J Biol Chem. 2014;289:5097-5108. doi: 10.1074/jbc.M113.533109.
18. Li Y, Challagundla KB, Sun XX, Zhang Q, Dai MS. MicroRNA-130a associates with ribosomal protein L11 to suppress c-Myc expression in response to UV irradiation. Oncotarget. 2015;6:1101-1114. doi: 10.18632/oncotarget.2728.
19. Eken SM, Jin H, Chernogubova E, Li Y, Simon N, Sun C, Korzuno-wicz G, Busch A, Bäcklund A, Österholm C, Razuvaev A, Renné T, Eckstein HH, Pelisek J, Eriksson P, González Díez M, Perisic Matic L, Schellinger IN, Raaz U, Leeper NJ, Hansson GK, Paulsson-Berne G, He-din U, Maegdefessel L. MicroRNA-210 enhances fibrous cap stability in advanced atherosclerotic lesions. Circ Res. 2017;120:633-644. doi: 10.1161/CIRCRESAHA.116.309318.
20. Wu G, Cai J, Han Y, Chen J, Huang ZP, Chen C, Cai Y, Huang H, Yang Y, Liu Y, Xu Z, He D, Zhang X, Hu X, Pinello L, Zhong D, He F, Yuan GC, Wang DZ, Zeng C. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation. 2014;130:1452-1465. doi: 10.1161/CIRCULATIONAHA.114.011675.
21. Lv J, Wang L, Zhang J, Lin R, Wang L, Sun W, Wu H, Xin S. Long noncoding RNA H19-derived miR-675 aggravates restenosis by targeting PTEN. Biochem Biophys Res Commun. 2018;497:1154-1161. doi: 10.1016/j.bbrc.2017.01.011.
22. Huang Y, Zheng Y, Jia L, Li W. Long noncoding RNA H19 promotes osteo-blast differentiation via TGF-β1/Smad3/HDAC signaling pathway by deriving miR-675. Stem Cells. 2015;33:3481-3492. doi: 10.1002/stem.2225.
23. Hnisz D, Day DS, Young RA. Insulated neighborhoods: structural and functional units of mammalian gene control. Cell. 2016;167:1188-1200. doi: 10.1016/j.cell.2016.10.024.
24. Levine M, Cattoglio C, Tjian R. Looping back to leap forward: transcription enters a new era. Cell. 2014;157:13-25. doi: 10.1016/j.cell.2014.02.009.
25. Apostolou E, Hochedlinger K. Chromatin dynamics during cellular reprogramming. Nature. 2013;502:462-471. doi: 10.1038/nature12749.
26. Chang TH, Huang HY, Hsu JB, Weng SL, Horng JT, Huang HD. An enhanced computational platform for investigating the roles of regulatory RNA and for identifying functional RNA motifs. BMC Bioinformatics. 2013;14 Suppl 2:S4. doi: 10.1186/1471-2105-14-S2-S4.
27. Greijer AE, van der Wall E. The role of hypoxia inducible factor 1 (HIF-1) in hypoxia induced apoptosis. J Clin Pathol. 2004;57:1009-1014. doi: 10.1136/jcp.2003.015032.
28. Chen D, Li M, Luo J, Gu W. Direct interactions between HIF-1 alpha and Mdm2 modulate p53 function. J Biol Chem. 2003;278:13595-13598. doi: 10.1074/jbc.C200694200.
29. Spin JM, Hsu M, Azuma J, Tedesco MM, Deng A, Dyer JS, Maegdefessel L, Dalman RL, Tsao PS. Transcriptional profiling and network analysis of the murine angiotensin II-induced abdominal aortic aneurysm. Physiol Ge-nomics. 2011;43:993-1003. doi: 10.1152/physiolgenomics.00044.2011.
30. Leeper NJ, Raiesdana A, Kojima Y, Kundu RK, Cheng H, Maegdefessel L, Toh R, Ahn GO, Ali ZA, Anderson DR, Miller CL, Roberts SC, Spin JM, de Almeida PE, Wu JC, Xu B, Cheng K, Quertermous M, Kundu S, Kortekaas KE, Berzin E, Downing KP, Dalman RL, Tsao PS, Schadt EE, Owens GK, Quertermous T. Loss of CDKN2B promotes p53-dependent smooth muscle cell apoptosis and aneurysm formation. Arterioscler Thromb Vasc Biol. 2013;33:e1-e10. doi: 10.1161/ATVBAHA.112.300399.
31. Dunn KW, Kamocka MM, McDonald JH. A practical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol. 2011;300:C723-C742. doi: 10.1152/ajpcell.00462.2010.
32. Söderberg O, Gullberg M, Jarvius M, Ridderstråle K, Leuchowius KJ, Jarvius J, Wester K, Hydbring P, Bahram F, Larsson LG, Landegren U. Direct observation of individual endogenous protein complexes in situ by proximity ligation. Nat Methods. 2006;3:995-1000. doi: 10.1038/nmeth947.
33. Wang Y, Wan C, Deng L, Liu X, Cao X, Gilbert SR, Bouxsein ML, Faugere MC, Guldberg RE, Gerstenfeld LC, Haase VH, Johnson RS, Schipani E, Clemens TL. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. J Clin Invest. 2007;117:1616-1626. doi: 10.1172/JCI31581.
34. Piret JP, Mottet D, Raes M, Michiels C. CoCl2, a chemical inducer of hypoxia-inducible factor-1, and hypoxia reduce apoptotic cell death in hepatoma cell line HepG2. Ann N Y Acad Sci. 2002;973:443-447. doi: 10.1111/j.1749-6632.2002.tb04680.x.
35. Minet E, Ernest I, Michel G, Roland I, Remacle J, Raes M, Michiels C. HIF1A gene transcription is dependent on a core promoter sequence encompassing activating and inhibiting sequences located upstream from the transcription initiation site and cis elements located within the 5'UTR. Biochem Biophys Res Commun. 1999;261:534-540. doi: 10.1006/bbrc.1999.0995.
36. Koizume S and Miyagi Y. Diverse mechanisms of Sp1-dependent transcriptional regulation potentially involved in the adaptive response of cancer cells to oxygen-deficient conditions. Cancers (Basel). 2015;8.pii:E2. doi: 10.3390/cancers8010002.
37. He S, Zhang H, Liu H, Zhu H. LongTarget: a tool to predict lncRNA DNA-binding motifs and binding sites via Hoogsteen base-pairing analysis. Bioinformatics. 2015;31:178-186. doi: 10.1093/bioinformatics/btu643.
38. Batista PJ, Chang HY. Long noncoding RNAs: cellular address codes in development and disease. Cell. 2013;152:1298-1307. doi: 10.1016/j.cell.2013.02.012.
39. Ørom UA,Shiekhattar R. Longnoncoding RN Asusherinanewerainthebiolo-gyofenhancers.Cell.2013;154:1190-1193.doi:10.1016/j.cell.2013.08.028.
40. Schmitz SU, Grote P, Herrmann BG. Mechanisms of long noncoding RNA function in development and disease. Cell Mol Life Sci. 2016;73:2491-2509. doi: 10.1007/s00018-016-2174-5.
41. Onoguchi M, Hirabayashi Y, Koseki H, Gotoh Y. A noncoding RNA regulates the neurogenin1 gene locus during mouse neocortical development. Proc Natl Acad Sci U S A. 2012;109:16939-16944. doi: 10.1073/pnas.1202956109.
42. Pachnis V, Belayew A, Tilghman SM. Locus unlinked to alpha-fetoprotein under the control of the murine raf and Rif genes. Proc Natl Acad Sci U S A. 1984;81:5523-5527. doi: 10.1073/pnas.81.17.5523.
43. Matouk IJ, Halle D, Raveh E, Gilon M, Sorin V, Hochberg A. The role of the oncofetal H19 lncRNA in tumor metastasis: orchestrating the EMT-MET decision. Oncotarget. 2016;7:3748-3765. doi: 10.18632/oncotarget.6387.
44. Raveh E, Matouk IJ, Gilon M, Hochberg A. The H19 Long non-coding RNA in cancer initiation, progression and metastasis - a proposed unifying theory. Mol Cancer. 2015;14:184. doi: 10.1186/s12943-015-0458-2.
45. Han Y, Xu H, Cheng J, Zhang Y, Gao C, Fan T, Peng B, Li B, Liu L, Cheng Z. Downregulation of long non-coding RNA H19 promotes P19CL6 cells proliferation and inhibits apoptosis during late-stage cardiac differentiation via miR-19b-modulated Sox6. Cell Biosci. 2016;6:58. doi: 10.1186/s13578-016-0123-5.
46. Cai B, Ma W, Bi C, Yang F, Zhang L, Han Z, Huang Q, Ding F, Li Y, Yan G, Pan Z, Yang B, Lu Y. Long noncoding RNA H19 mediates melatonin inhibition of premature senescence of c-kit(+) cardiac progenitor cells by promoting miR-675. J Pineal Res. 2016;61:82-95. doi: 10.1111/jpi.12331.
47. Voellenkle C, Garcia-Manteiga JM, Pedrotti S, Perfetti A, De Toma I, Da Silva D, Maimone B, Greco S, Fasanaro P, Creo P, Zaccagnini G, Gaetano C, Martelli F. Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. Sci Rep. 2016;6:24141. doi: 10.1038/srep24141.
48. Liu L, An X, Li Z, Song Y, Li L, Zuo S, Liu N, Yang G, Wang H, Cheng X, Zhang Y, Yang X, Wang J. The H19 long noncoding RNA is a novel negative regulator of cardiomyocyte hypertrophy. Cardiovasc Res. 2016;111:56-65. doi: 10.1093/cvr/cvw078.
49. Hadji F, Boulanger MC, Guay SP, Gaudreault N, Amellah S, Mkannez G, Bouchareb R, Marchand JT, Nsaibia MJ, Guauque-Olarte S, Pibarot P, Bouchard L, Bossé Y, Mathieu P. Altered DNA methylation of long noncoding RNA H19 in calcific aortic valve disease promotes mineralization by silencing NOTCH1. Circulation. 2016;134:1848-1862. doi: 10.1161/CIRCULATIONAHA.116.023116.
50. Berteaux N, Lottin S, Monté D, Pinte S, Quatannens B, Coll J, Hon-dermarck H, Curgy JJ, Dugimont T, Adriaenssens E. H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1. J Biol Chem. 2005;280:29625-29636. doi: 10.1074/jbc.M504033200.
51. Dugimont T, Montpellier C, Adriaenssens E, Lottin S, Dumont L, Iotsova V, Lagrou C, Stéhelin D, Coll J, Curgy JJ. The H19 TATA-less promoter is efficiently repressed by wild-type tumor suppressor gene product p53. Oncogene. 1998;16:2395-2401. doi: 10.1038/sj.onc.1201742.
52. Barsyte-Lovejoy D, Lau SK, Boutros PC, Khosravi F, Jurisica I, Andrulis IL, Tsao MS, Penn LZ. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis. Cancer Res. 2006;66:5330-5337. doi: 10.1158/0008-5472.CAN-06-0037.
53. Matouk IJ, DeGroot N, Mezan S, Ayesh S, Abu-lail R, Hochberg A, Galun E. The H19 non-coding RNA is essential for human tumor growth. PLoS One. 2007;2:e845. doi: 10.1371/journal.pone.0000845.
54. Matouk IJ, Mezan S, Mizrahi A, Ohana P, Abu-Lail R, Fellig Y, Degroot N, Galun E, Hochberg A. The oncofetal H19 RNA connection: hypoxia, p53 and cancer. Biochim Biophys Acta. 2010;1803:443-451. doi: 10.1016/j.bbamcr.2010.01.010.
55. Erdozain OJ, Pegrum S, Winrow VR, Horrocks M, Stevens CR. Hypoxia in abdominal aortic aneurysm supports a role for HIF-1α and Ets-1 as drivers of matrix metalloproteinase upregulation in human aortic smooth muscle cells. J Vasc Res. 2011;48:163-170. doi: 10.1159/000318806.
56. Choke E, Cockerill GW, Dawson J, Chung YL, Griffiths J, Wilson RW, Lof-tus IM, Thompson MM. Hypoxia at the site of abdominal aortic aneurysm rupture is not associated with increased lactate. Ann N Y Acad Sci. 2006;1085:306-310. doi: 10.1196/annals.1383.005.
57. Sano M, Sasaki T, Hirakawa S, Sakabe J, Ogawa M, Baba S, Zaima N, Tanaka H, Inuzuka K, Yamamoto N, Setou M, Sato K, Konno H, Unno N. Lymphangiogenesis and angiogenesis in abdominal aortic aneurysm. PLoS One. 2014;9:e89830. doi: 10.1371/journal.pone.0089830.
58. Strauss E, Waliszewski K, Oszkinis G, Staniszewski R. Polymorphisms of genes involved in the hypoxia signaling pathway and the development of abdominal aortic aneurysms or large-artery atherosclerosis. J Vasc Surg. 2015;61:1105-13.e3. doi: 10.1016/j.jvs.2014.02.007.
59. Ailawadi G, Moehle CW, Pei H, Walton SP, Yang Z, Kron IL, Lau CL, Owens GK. Smooth muscle phenotypic modulation is an early event in aortic aneurysms. J Thorac Cardiovasc Surg. 2009;138:1392-1399. doi: 10.1016/j.jtcvs.2009.07.075.
60. Henderson EL, Geng YJ, Sukhova GK, Whittemore AD, Knox J, Libby P. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation. 1999;99:96-104. doi: 10.1161/01.CIR.99.1.96.
61. Yang L, Shen L, Li G, Yuan H, Jin X, Wu X. Silencing of hypoxia inducible factor-1α gene attenuated angiotensin Ⅱ-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice. Atherosclerosis. 2016;252:40-49. doi: 10.1016/j.atherosclerosis.2016.07.010.
62. Zhu Q, Wang Z, Xia M, Li PL, Van Tassell BW, Abbate A, Dhaduk R, Li N. Silencing of hypoxia-inducible factor-1α gene attenuated angiotensin II-induced renal injury in Sprague-Dawley rats. Hypertension. 2011;58:657-664. doi: 10.1161/HYPERTENSIONAHA.111.177626.
63. Tsai SH, Huang PH, Hsu YJ, Peng YJ, Lee CH, Wang JC, Chen JW, Lin SJ. Inhibition of hypoxia inducible factor-1α attenuates abdominal aortic aneurysm progression through the down-regulation of matrix metalloproteinases. Sci Rep. 2016;6:28612. doi: 10.1038/srep28612.
64. Takahara Y, Tokunou T, Kojima H, Hirooka Y, Ichiki T. Deletion of hypoxia-inducible factor-1α in myeloid lineage exaggerates angiotensin II-induced formation of abdominal aortic aneurysm. Clin Sci (Lond). 2017;131:609-620. doi: 10.1042/CS20160865.
65. Piret JP, Mottet D, Raes M, Michiels C. Is HIF-1alpha a pro- or an antiapoptotic protein? Biochem Pharmacol. 2002;64:889-892. doi: 10.1016/ S0006-2952(02)01155-3.
66. Juan V, Crain C, Wilson C. Evidence for evolutionarily conserved secondary structure in the H19 tumor suppressor RNA. Nucleic Acids Res. 2000;28:1221-1227. doi: 10.1093/nar/28.5.1221.
67. Lin A, Li C, Xing Z, Hu Q, Liang K, Han L, Wang C, Hawke DH, Wang S, Zhang Y, Wei Y, Ma G, Park PK, Zhou J, Zhou Y, Hu Z, Zhou Y, Marks JR, Liang H, Hung MC, Lin C, Yang L. The LINK-A lncRNA activates nor-moxic HIF1α signalling in triple-negative breast cancer. Nat Cell Biol. 2016;18:213-224. doi: 10.1038/ncb3295.
68. Giovarelli M, Bucci G, Ramos A, Bordo D, Wilusz CJ, Chen CY, Puppo M, Briata P, Gherzi R. H19 long noncoding RNA controls the mRNA decay promoting function of KSRP. Proc Natl Acad Sci U S A. 2014;111:E5023-E5028. doi: 10.1073/pnas.1415098111.